These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19635676)

  • 41. Generation of induced pluripotent stem cells (UCLi024-A) from a patient with argininosuccinate lyase deficiency carrying a homozygous c.437G > A (p.Arg146Gln) mutation.
    Duff C; Islam M; Gagliano O; Pramod H; Rashidi H; Kurian MA; Gissen P; Baruteau J
    Stem Cell Res; 2024 Apr; 76():103365. PubMed ID: 38422816
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A neonatal screening test for argininosuccinic acid lyase deficiency and other urea cycle disorders.
    Talbot HW; Sumlin AB; Naylor EW; Guthrie R
    Pediatrics; 1982 Oct; 70(4):526-31. PubMed ID: 7122151
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Natural history of epilepsy in argininosuccinic aciduria provides new insights into pathophysiology: A retrospective international study.
    Elkhateeb N; Olivieri G; Siri B; Boyd S; Stepien KM; Sharma R; Morris AAM; Hartley T; Crowther L; Grunewald S; Cleary M; Mundy H; Chakrapani A; Lachmann R; Murphy E; Santra S; Uudelepp ML; Yeo M; Bernhardt I; Sudakhar S; Chan A; Mills P; Ridout D; Gissen P; Dionisi-Vici C; Baruteau J
    Epilepsia; 2023 Jun; 64(6):1612-1626. PubMed ID: 36994644
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype.
    Kölker S; Valayannopoulos V; Burlina AB; Sykut-Cegielska J; Wijburg FA; Teles EL; Zeman J; Dionisi-Vici C; Barić I; Karall D; Arnoux JB; Avram P; Baumgartner MR; Blasco-Alonso J; Boy SP; Rasmussen MB; Burgard P; Chabrol B; Chakrapani A; Chapman K; Cortès I Saladelafont E; Couce ML; de Meirleir L; Dobbelaere D; Furlan F; Gleich F; González MJ; Gradowska W; Grünewald S; Honzik T; Hörster F; Ioannou H; Jalan A; Häberle J; Haege G; Langereis E; de Lonlay P; Martinelli D; Matsumoto S; Mühlhausen C; Murphy E; de Baulny HO; Ortez C; Pedrón CC; Pintos-Morell G; Pena-Quintana L; Ramadža DP; Rodrigues E; Scholl-Bürgi S; Sokal E; Summar ML; Thompson N; Vara R; Pinera IV; Walter JH; Williams M; Lund AM; Garcia-Cazorla A
    J Inherit Metab Dis; 2015 Nov; 38(6):1059-74. PubMed ID: 25875216
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Experience with the treatment of argininosuccinic aciduria during pregnancy.
    Reid L; Perreault E; Lafrance G; Clarke JT
    J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S191-5. PubMed ID: 19585269
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Molecular basis of urea cycle disorders].
    Matsuda I; Matsuura T; Hoshide R; Uchino T; Matsubasa T
    Nihon Rinsho; 1993 Feb; 51(2):520-4. PubMed ID: 8464164
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Argininosuccinate Lyase Deficiency Causes an Endothelial-Dependent Form of Hypertension.
    Kho J; Tian X; Wong WT; Bertin T; Jiang MM; Chen S; Jin Z; Shchelochkov OA; Burrage LC; Reddy AK; Jiang H; Abo-Zahrah R; Ma S; Zhang P; Bissig KD; Kim JJ; Devaraj S; Rodney GG; Erez A; Bryan NS; Nagamani SCS; Lee BH
    Am J Hum Genet; 2018 Aug; 103(2):276-287. PubMed ID: 30075114
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Complementation in argininosuccinate synthetase and argininosuccinate lyase deficiencies in human fibroblasts.
    Cathelineau L; Pham Dinh D; Briand P; Kamoun P
    Adv Exp Med Biol; 1982; 153():101-10. PubMed ID: 7164890
    [No Abstract]   [Full Text] [Related]  

  • 49. Two novel mutations (E86A, R113W) in argininosuccinate lyase deficiency and evidence for highly variable splicing of the human argininosuccinate lyase gene.
    Linnebank M; Homberger A; Rapp B; Winter C; Marquardt T; Harms E; Koch HG
    J Inherit Metab Dis; 2000 Jun; 23(4):308-12. PubMed ID: 10896281
    [No Abstract]   [Full Text] [Related]  

  • 50. Evaluation of endogenous nitric oxide synthesis in congenital urea cycle enzyme defects.
    Nagasaka H; Tsukahara H; Yorifuji T; Miida T; Murayama K; Tsuruoka T; Takatani T; Kanazawa M; Kobayashi K; Okano Y; Takayanagi M
    Metabolism; 2009 Mar; 58(3):278-82. PubMed ID: 19217439
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neonatal screening for citrullinaemia.
    Sander J; Janzen N; Sander S; Steuerwald U; Das AM; Scholl S; Trefz FK; Koch HG; Häberle J; Korall H; Marquardt I; Korenke C
    Eur J Pediatr; 2003 Jun; 162(6):417-20. PubMed ID: 12684898
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Progressive liver fibrosis in late-onset argininosuccinate lyase deficiency.
    Mori T; Nagai K; Mori M; Nagao M; Imamura M; Iijima M; Kobayashi K
    Pediatr Dev Pathol; 2002; 5(6):597-601. PubMed ID: 12370774
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low prevalence of argininosuccinate lyase deficiency among inherited urea cycle disorders in Korea.
    Kim D; Ko JM; Kim YM; Seo GH; Kim GH; Lee BH; Yoo HW
    J Hum Genet; 2018 Jul; 63(8):911-917. PubMed ID: 29773863
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Argininosuccinic Aciduria-A Rare Indication for Liver Transplant: Report of Two Cases.
    Yankol Y; Mecit N; Kanmaz T; Acarli K; Kalayoglu M
    Exp Clin Transplant; 2017 Oct; 15(5):581-584. PubMed ID: 26768012
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metabolic cooperation between argininosuccinate synthetase and argininosuccinate lyase deficient human fibroblasts.
    Davidson JS; Baumgarten IM; Harley EH
    Exp Cell Res; 1984 Feb; 150(2):367-78. PubMed ID: 6692857
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neonatal factors related to survival and intellectual and developmental outcome of patients with early-onset urea cycle disorders.
    Pontoizeau C; Roda C; Arnoux JB; Vignolo-Diard P; Brassier A; Habarou F; Barbier V; Grisel C; Abi-Warde MT; Boddaert N; Kuster A; Servais A; Kaminska A; Hennequin C; Dupic L; Lesage F; Touati G; Valayannopoulos V; Chadefaux-Vekemans B; Oualha M; Eisermann M; Ottolenghi C; de Lonlay P
    Mol Genet Metab; 2020 Jun; 130(2):110-117. PubMed ID: 32273051
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The human argininosuccinate synthetase locus and citrullinemia.
    Beaudet AL; O'Brien WE; Bock HG; Freytag SO; Su TS
    Adv Hum Genet; 1986; 15():161-96, 291-2. PubMed ID: 3513483
    [No Abstract]   [Full Text] [Related]  

  • 58. [Molecular genetics of urea cycle diseases].
    Ohtake A; Mori M
    Seikagaku; 1990 Sep; 62(9):1170-7. PubMed ID: 2258657
    [No Abstract]   [Full Text] [Related]  

  • 59. Long-term follow-up of 12 patients with the late-onset variant of argininosuccinic acid lyase deficiency: no impairment of intellectual and psychomotor development during therapy.
    Widhalm K; Koch S; Scheibenreiter S; Knoll E; Colombo JP; Bachmann C; Thalhammer O
    Pediatrics; 1992 Jun; 89(6 Pt 2):1182-4. PubMed ID: 1594374
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Argininosuccinate neurotoxicity and prevention by creatine in argininosuccinate lyase deficiency: An in vitro study in rat three-dimensional organotypic brain cell cultures.
    Diez-Fernandez C; Hertig D; Loup M; Diserens G; Henry H; Vermathen P; Nuoffer JM; Häberle J; Braissant O
    J Inherit Metab Dis; 2019 Nov; 42(6):1077-1087. PubMed ID: 30907007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.